Canada Life’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $775K | Buy |
7,405
+4,293
| +138% | +$449K | ﹤0.01% | 1500 |
|
|
2025
Q1 | $364K | Hold |
3,112
| – | – | ﹤0.01% | 1661 |
|
|
2024
Q4 | $263K | Sell |
3,112
-239
| -7% | -$20.2K | ﹤0.01% | 1726 |
|
|
2024
Q3 | $301K | Sell |
3,351
-4,248
| -56% | -$382K | ﹤0.01% | 1757 |
|
|
2024
Q2 | $611K | Buy |
7,599
+229
| +3% | +$18.4K | ﹤0.01% | 1632 |
|
|
2024
Q1 | $588K | Buy |
7,370
+4,258
| +137% | +$340K | ﹤0.01% | 1652 |
|
|
2023
Q4 | $246K | Hold |
3,112
| – | – | ﹤0.01% | 1807 |
|
|
2023
Q3 | $217K | Buy |
3,112
+1,700
| +120% | +$119K | ﹤0.01% | 1842 |
|
|
2023
Q2 | $102K | Sell |
1,412
-129
| -8% | -$9.32K | ﹤0.01% | 1924 |
|
|
2023
Q1 | $95K | Hold |
1,541
| – | – | ﹤0.01% | 1985 |
|
|
2022
Q4 | $119K | Hold |
1,541
| – | – | ﹤0.01% | 1959 |
|
|
2022
Q3 | $69K | Hold |
1,541
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q2 | $59K | Hold |
1,541
| – | – | ﹤0.01% | 2023 |
|
|
2022
Q1 | $68K | Hold |
1,541
| – | – | ﹤0.01% | 2089 |
|
|
2021
Q4 | $58K | Hold |
1,541
| – | – | ﹤0.01% | 2134 |
|
|
2021
Q3 | $51K | Hold |
1,541
| – | – | ﹤0.01% | 2229 |
|
|
2021
Q2 | $104K | Sell |
1,541
-514
| -25% | -$34.7K | ﹤0.01% | 2081 |
|
|
2021
Q1 | $115K | Hold |
2,055
| – | – | ﹤0.01% | 2067 |
|
|
2020
Q4 | $167K | Hold |
2,055
| – | – | ﹤0.01% | 2008 |
|
|
2020
Q3 | $146K | Hold |
2,055
| – | – | ﹤0.01% | 1960 |
|
|
2020
Q2 | $168K | Buy |
2,055
+445
| +28% | +$36.4K | ﹤0.01% | 1946 |
|
|
2020
Q1 | $96K | Hold |
1,610
| – | – | ﹤0.01% | 1985 |
|
|
2019
Q4 | $165K | Buy |
+1,610
| New | +$165K | ﹤0.01% | 1967 |
|
|
2019
Q3 | – | Sell |
-3,035
| Closed | -$78K | – | 1227 |
|
|
2019
Q2 | $78K | Buy |
+3,035
| New | +$78K | ﹤0.01% | 2302 |
|